Home

Subscription

September 2017 issue

August 2017 issue

July 2017 issue

June 2017 issue

May 2017 issue

April 1, 2017 issue

March 2017 issue

February 2017 issue

January 2017 issue



BACK ISSUES

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006


2013 Issues

December 2013 Issue
• New Drug Review: Dabrafenib mesylate (Tafinlar)
• New Drug Review: Trametinib dimethyl sulfoxide (Mekinist)
• Index for 2013


November 2013 Issue
• Feature - Inspiration!
• New Drug Review: Crofelemer (Fulyzaq)


October 2013 Issue
• Feature - Obtaining Health Insurance that Isn't Understood Using a System that Isn't Working - And the Situation Will Get Worse if there is not Compromise!
• New Drug Review: Ospemifene (Osphena)


September 2013 Issue
• Feature - Boards of Pharmacy Should Discontinue Issuing Licenses to Pharmacies that Sell Tobacco Products and to Pharmacies that are in Facilities that Sell Tobacco Products
• New Drug Review: Vilanterol trifenatate/fluticasone furoate (Breo Ellipta)


August 2013 Issue
• Feature - Mail-order Pharmacy Threatens the Role of Pharmacists as Health Professionals
• New Drug Review: Dimethyl fumarate (Tecfidera)


July 2013 Issue
• Feature - Pharmacists Be On Guard! For the Protection of Your Patients and Yourselves
• New Drug Review: Lorcaserin (Belviq)


June 2013 Issue
• Feature - Walgreens Challenges CVS in the Race to the Bottom - But No Individuals are Accountable!
• New Drug Review: Alogliptin benzoate (Nesina)


May 2013 Issue
• Feature - Pfizer's Viagra Promotion Puts Patients at Risk and is an Insult to Local Pharmacists
• New Drug Review: Canagliflozin (Invokana)


April 2013 Issue
• Feature - Pharmacy as a Career Choice? YES!
• New Drug Review: Apixaban (Eliquis)


March 2013 Issue
• Feature - "I Quit CVS Today"
• New Drug Review: Linaclotide (Linzess)


February 2013 Issue
• Feature - Express Scripts Almost Discovers Conscience - But Fails to Do So!
• New Drug Review: Teriflunomide (Aubagio)


January 2013 Issue
• Feature - The APhA and ASHP Should Merge!
• New Drug Review: Aclidinium bromide (Tudorza Pressair)
• New Therapeutic Agents Marketed in the United States in 2012 (Table)